Hu et al developed a clinical prediction rule for identifying a patient at risk for recurrent Clostridium difficile disease following initial therapy. This can help to identify patients who may require closer monitoring and more aggressive management. The authors are from Beth Israel Deaconess Medical Center in Boston and Mater Misericordiae University Hospital in Dublin, Ireland.